Elliot Ryan

Elliot's practice focuses on advising international and domestic private investors and corporates on cross border acquisitions and divestments, joint ventures and private equity transactions with a focus on real assets, digital infrastructure and industrials/manufacturing transactions. Elliot has also spent time on secondment working in the internal legal teams at the multinational pharmaceutical group Sandoz (formerly a division of Novartis) as well as the Kantar Group.

Financial Sponsor

• Advised KKR as part of its GBP 5.75 billion consortium take-private bid for the DCC Energy Group.
• Advised Silver Lake on its divestment of multiple business units from its portfolio company Software AG.
• Advised AURELIUS on the acquisition of Footasylum from JD Sports.
• Advised Apollo Global Management on multiple bids and acquisitions.
• Advised Trill Impact on multiple acquisitions and divestments for its portfolio company Nordomatic.
• Advising Fiera Infrastructure on its acquisition of a 50% equity interest in Isle of Wight ferry operator Wightlink from Basalt Infrastructure Partners (and related syndication).

Real Estate / Digital Infrastructure

• Advised Equinix on its USD 525 million joint venture with GIC, Singapore's sovereign wealth fund, for the development and operation of two xScale data centres in Seoul, Korea.
• Advised the Shimao Group on their sale of central London real estate assets.
• Advised the Fattal Hotels Group on its acquisition of the Dilly Hotel, London (283 rooms).
• Advised Avelios Group on their joint venture with investment management firm Crestline Investors and their subsequent acquisition of the East London Hotel, London (161 rooms).
• Advised an owner-operator on the cross-border leveraged acquisition of a portfolio of 11 Penta-branded hotels (1,808 rooms) across Europe, completed in partnership with InterContinental Hotels Group (IHG).
• Advised Daiwa House on its joint venture with Lendlease to develop the final BtS scheme at Elephant Park.

Corporate M&A

• Advised Sika AG on its EUR 5.3 billion acquisition of the MBCC Group including its simultaneous divestment of MBCC Group's concrete admixtures business to Cinven.
• Advising Sandoz AG (formerly a division of Novartis) on their buy-out acquisition of their generics and biosimilar operating partner, Rowa Pharmaceuticals, in Ireland.
• Advised Merit Medical, a US-based medical devices company, on its acquisition of STD pharmaceuticals, its first pharmaceutical business.
• Advised Uniphore Technologies Inc on its acquisition of the Red Box Group, a UK based leading AI enhanced voice recording specialist.
• Advised Tencent on numerous early stage investments within the technology space, including the Series B and C funding of BitBio Ltd, a UK based synthetic biology start up.
• Advised the management team of the DataFlow Group on a sale to global investment firm Arcapita.
• Advised the Travelex management team in respect of the implementation their management incentive scheme.